Gene · 2195
Papers4,590
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 4,590
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ERK hyperactivation serves as a unified mechanism of escape in intrinsic and acquired CDK4/6 inhibitor resistance in acral lentiginous melanoma. | Oncogene | 2024 | 38066089 | PubTator, text mining | PubMed |
| Current status and perspectives of genetic testing in gastrointestinal cancer (Review). | Oncol Lett | 2024 | 38058469 | PubTator, text mining | PubMed |
| Identifying survival of pan-cancer patients under immunotherapy using genomic mutation signature with large sample cohorts. | J Mol Med (Berl) | 2024 | 37978056 | PubTator, text mining | PubMed |
| A comparison between mutational profiles in tumour tissue DNA and circulating tumour DNA in head and neck squamous cell carcinoma - A systematic review. | Mutat Res Rev Mutat Res | 2024 | 37977279 | PubTator, text mining | PubMed |
| Establishment and characterization of a novel hilar cholangiocarcinoma cell line, CBC3T-1. | Hum Cell | 2024 | 37966669 | PubTator, text mining | PubMed |
| FAT1 inhibits AML autophagy and proliferation via downregulating ATG4B expression. | Biochim Biophys Acta Gen Subj | 2024 | 37952564 | PubTator, text mining | PubMed |
| Whole exome sequencing uncovers HRAS mutations as potential mediators of resistance to metronomic chemotherapy. | Gene | 2024 | 37918550 | PubTator, text mining | PubMed |
| Integrating bulk and single-cell data to predict the prognosis and identify the immune landscape in HNSCC. | J Cell Mol Med | 2024 | 37882107 | PubTator, text mining | PubMed |
| Membranous nephropathy-diagnosis and identification of target antigens. | Nephrol Dial Transplant | 2024 | 37863839 | PubTator, text mining | PubMed |
| A case of protocadherin FAT1-positive membranous nephropathy secondary to hematopoietic stem-cell transplantation. | J Nephrol | 2024 | 37815750 | PubTator, text mining | PubMed |
| Preliminary assessment of automated radiology report generation with generative pre-trained transformers: comparing results to radiologist-generated reports. | Jpn J Radiol | 2024 | 37713022 | PubTator, text mining | PubMed |
| Distinct clinical profiles and mutation landscapes of gliomas originating from the neocortex, mesocortex, and cerebellum. | Genes Dis | 2024 | 37588233 | PubTator, text mining | PubMed |
| Sex differences in the association between dual-energy x-ray absorptiometry-measured body composition and periodontitis. | J Periodontol | 2024 | 37505475 | PubTator, text mining | PubMed |
| Characteristics of Molecular Genetic Mutations and Their Correlation with Prognosis in Adolescent and Adult Patients with Acute Lymphoblastic Leukemia. | Oncology | 2024 | 37437551 | PubTator, text mining | PubMed |
| Characteristics and prognosis of EGFR mutations in small cell lung cancer patients in the NGS era. | Clin Transl Oncol | 2024 | 37436674 | PubTator, text mining | PubMed |
| 92 Mb/s Fat-Intrabody Communication (Fat-IBC) With Low-Cost WLAN Hardware. | IEEE Trans Biomed Eng | 2024 | 37432837 | PubTator, text mining | PubMed |
| Combined Hepatocellular-Cholangiocarcinoma With Ductal Plate Malformation Pattern: A Case Report With Molecular Analysis. | Int J Surg Pathol | 2024 | 37128663 | PubTator, text mining | PubMed |
| Association of FAT1 with focal epilepsy and correlation between seizure relapse and gene expression stage. | Seizure | 2024 | 36941137 | PubTator, text mining | PubMed |
| [Effect of Sedentary behaviors on the Interaction Between the FTO Gene and Adiposity Levels in Chilean Adults - Results from the GENADIO Study]. | Rev Med Chil | 2023 | 39093190 | PubTator, text mining | PubMed |
| Tislelizumab plus nimotuzumab is effective against recurrent or metastatic oral squamous cell carcinoma among patients with a performance status score ≥ 2: a retrospective study. | Front Oncol | 2023 | 38293699 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2195/papers?page=21